Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).
about
Radiotherapy using IMRT boosts after hyperbaric oxygen therapy with chemotherapy for glioblastoma.Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes.Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO).
P2860
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Accelerated intensity-modulate ...... escalation study (ISIDE-BT-1).
@en
Accelerated intensity-modulate ...... phase I dose-escalation study
@nl
type
label
Accelerated intensity-modulate ...... escalation study (ISIDE-BT-1).
@en
Accelerated intensity-modulate ...... phase I dose-escalation study
@nl
prefLabel
Accelerated intensity-modulate ...... escalation study (ISIDE-BT-1).
@en
Accelerated intensity-modulate ...... phase I dose-escalation study
@nl
P2093
P2860
P50
P1476
Accelerated intensity-modulate ...... -escalation study (ISIDE-BT-1)
@en
P2093
Francesco Deodato
Mariangela Massaccesi
Marica Ferro
Mario Balducci
Savino Cilla
P2860
P2888
P304
P356
10.1007/S10147-012-0462-0
P577
2012-08-15T00:00:00Z